Recent events have forced member organizations to examine the gaps in the current biomedical research system - exposing areas of weakness, while also highlighting areas of immense opportunity. This ‘open... read more →
For the first time, the members’ meeting planning committee is organizing a session dedicated exclusively to development and fundraising. In this interactive session, we will discuss best practices and proven... read more →
This session will discuss successful strategies used within an organization’s governance structure to manage expectations of key stakeholders, specifically donors and foundation leadership. Using presentations of case studies from member... read more →
Dr. Hannah Valantine, NIH’s first Chief Officer for Scientific Workforce Diversity, will present NIH’s plans to support scientific workforce diversity and inclusion efforts in the face of COVID-19. NIH’s plans... read more →
This unprecedented and continuously evolving COVID-19 pandemic has caused turbulence in the lives of the global public. Organizations worldwide are doing their best to learn and understand the impact of... read more →
Social media can be an important tool for nonprofits to build strong communities online and further their reach. Are you using your social media channels effectively? In this session, we... read more →
Breakout Session: A Natural History of HRA & Patient Registries Informed by member and non-member experiences, challenges, questions, and accomplishments, this session will present and discuss organizations’ patient registries efforts.... read more →
This session focused on the strengthening trend of incorporating the patient voice and values into funded research efforts. Patients are invited to be involved in various steps along the project-funding... read more →
In this session, we explored best practices for RFA development for new scientific areas, and marketing existing and new RFAs. In particular, speakers discussed how to get input from innovators... read more →
Venture philanthropy does not come without its fair share of controversy. It remains a challenge for nonprofits, philanthropists, patients, start-ups and the general public to determine how – and if... read more →